News & Events
- Showing 1–24 of 54 items
We are committed to producing high-quality molecular controls which can help you provide accurate and reliable test results.
Is this "Tripledemic" keeping you up at night? We have developed the broadest line of respiratory and coronavirus controls and panels to help you confidently monitor the continued performance of your multiplexed assays.
Use NATtrol MS2 Bacteriophage Stock as your internal process control for rt-PCR assays today! ZeptoMetrix® NATtrol™ MS2 Bacteriophage Stock, NATMS2-STQ, has been chemically inactivated, resulting in a product that shows increased stability, reproducibility, and lot-to-lot consistency over live MS2.
ZeptoMetrix® Launches NATtrol™ Monkeypox Virus External Run Control: NATMPXV-ERC
2022 North East Laboratory Conference
Dates: October 18 - 19
Where: Portland, ME
Booth #: 68
2022 Southern California Branch of the American Society for Microbiology (SCASM)
Dates: October 20 - 22
Where: La Jolla, CA
Booth #: 212
2022 Association for Molecular Pathology (AMP)
Dates: November 03 - 05
Where: Phoenix, AZ
Booth #: 1020/1022
ZeptoMetrix® has successfully completed its first EU Quality Management System Audit from British Standards Institution BSI, NB 2797, one of the notified bodies under the new In Vitro Diagnostics Regulation (IVDR).
New! Monkeypox Recombinant Stock Order your NATtrol™ Recombinant Monkeypox Virus Stock now; formulated with purified, ready to use and refrigerator stable. ORDER TODAY!
NATtrol Flu/RSV/SARS-CoV-2 External Run Control includes 4 targets: Flu A (A/Brisbane/10/07), Flu B (B/Florida/02/06), RSV B (CH93(18)-18), SARS-CoV-2 (USA-WA1/2020).
ZeptoMetrix® launches the NATtrol™ Bacteriophage MS2 quantitative stock: NATMS2-STQ. This product is intended for use as an internal process control for molecular diagnostic assays.
ZeptoMetrix® is committed to women’s health. Two new vaginal molecular QC controls, NATVPOS-6C Vaginal Positive Control and NATVNEG-6C Vaginal Negative Control, for in vitro diagnostic use are now available.
ZeptoMetrix launches NEW NATtrol Joint Infection Panel - NATJIP-BIO
Performance verification is a critical component of implementing a diagnostic test in a clinical lab and can be time consuming and costly A verification protocol and organism panel were developed in collaboration with ZeptoMetrix ® to verify all analyte detections for the BioFire ® Joint Infection.
Did you miss our free webinar? Watch the recording now Webinar: Best Practices for Maintaining Quality in Molecular Diagnostic Testing.Learn about considerations for implementing a quality management system for your laboratory.
Did you miss our free webinar? Watch the recording now
Looking ahead in the clinical lab: What’s next after COVID-19?
Serology testing demonstrates that antibodies to SARS-CoV-2 S1-RBD correlate with neutralization of virus infection of Vero E6 cells
Microneutralization end point–dilution assays were performed at ZeptoMetrix. SARS-CoV-2 virus, isolate USA-WA1/2020, NR-52281 (CDC and BEI Resources, National Institute of Allergy and Infectious Diseases, NIH) was used for microneutralization end point–dilution assays.
New ZeptoMetrix® NATtrol™ SARS-CoV-2 Omicron Control Now Available
ZeptoMetrix® new SARS-CoV-2 Lineage B.1.1.529; Omicron Variant CF (Heat Inactivated)is available for immediate Research and Assay Development.
ZeptoMetrix® to release new Non-Infectious SARS-CoV-2 Omicron External Run Control - NATCOV2(OMC)-ERC. Order today!
Development of a Laboratory Verification Protocol for Qualitative and Semi-Quantitative Detections in a Multiplex Syndromic Pneumonia Panel
Reduce Errors and Increase Confidence in Testing with Quality Controls - The Science of Real Life
ZeptoMetrix® launches the SARS-CoV-2 Omicron Control. Now available for pre-order.